VivoSeq
Other

Critically Ill Patients

0

Pipeline Programs↗

25

Active Trials↗

3

Companies Involved↗

Critically Ill Patients is an early-stage landscape with 0 programs across 3 companies. The most active players are GSK, Johnson & Johnson Pharmaceutical Research & Development, L.L.C., Takeda.

Intelligence

Pipeline Metrics

Competitive Density

39/100

Pipeline Velocity

19/100

Mech. Concentration

N/A

Completion Rate

77/100

Attrition Rate

14/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

GSK logo

GSK

0 programs

PreclinicalJohnson & Johnson Pharmaceutical Research & Development, L.L.C. logo

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

0 programs

PreclinicalTakeda logo

Takeda

0 programs

Preclinical

Pipeline

Programs by Phase

No pipeline programs currently tracked for this disease.

Analysis

Trial Status

111

clinical trials

Completed55 · 50%
Unknown status15 · 14%
Terminated14 · 13%
Recruiting13 · 12%
Not yet recruiting7 · 6%
Active, not recruiting4 · 4%
Other3 · 3%

Clinical Trials

Trial Activity

111 trials

Population Pharmacokinetics of Remifentanil in Low-Weight Critically Ill Patients
Recruiting·FFudan University·N/A·NCT07301970·45 enrolled
Efficacy of the Use of Vasopressin as a Primary Vasoconstrictor in Critically Ill Patients
Recruiting·UUniversity of Thessaly·Phase 4·NCT06265259·145 enrolled
The Effects of Pancreatic Enzyme Supplementation in Critically Ill Patients on Enteral Feeding
Recruiting·SSeoul National University Hospital·N/A·NCT05112328·170 enrolled
Effectiveness of Midodrine as an Adjuvant to Norepinephrine in Weaning Critically Ill Patients From Vasopressors
Recruiting·SSohag University·N/A·NCT06930235·112 enrolled
Comparison of the Clinical Efficacy of Ampicillin/Sulbactam and Cefoperazone/Sulbactam Against Multidrug Resistant Acinetobacter Baumannii Infections in Critically Ill Patients
Recruiting·—·N/A·NCT07118384·50 enrolled
Advancing Brain Outcomes in Pediatric Critically Ill Patients Sedated With Volatile AnEsthestic Agents
Recruiting·SSunnybrook Health Sciences Centre·Phase 3·NCT05867472·60 enrolled
The Effect of Dexmedetomidine on the Renal Functions in Septic Critically Ill Patients
Recruiting·—·Phase 4·NCT06570187·128 enrolled
Pharmacological Reversal of Neuromuscular Blockade in Critically Ill Patients
Recruiting·SSeoul National University Hospital·N/A·NCT05993390·30 enrolled
Intensive Versus Conventional Hyperglycemic Control in Hospitalized Non-critically Ill Patients
Recruiting·RRabin Medical Center·N/A·NCT03510078·600 enrolled
"Effect of Albumin Combined With Furosemide in Critically Ill Patients With Fluid Overload: Impact on Urine Output and Renal Function"
Recruiting·JJose J Zaragoza, MD MSc·N/A·NCT07417969·56 enrolled
Fecal Microbial Transplantation in Critically Ill Patients With Severe Infections.
Recruiting·SShanghai 10th People's Hospital·N/A·NCT05578196·110 enrolled
Vitamin D3 Supplementation in Critically Ill Patients Undergoing CRRT
Recruiting·UUniwersytecki Szpital Kliniczny w Opolu·Phase 4·NCT05657678·138 enrolled
Low-intensity Versus Medium-intensity Continuous Kidney Replacement Therapy for Critically Ill Patients
Recruiting·JJikei University School of Medicine·Phase 2/3·NCT06014801·400 enrolled
Tight Versus Liberal Blood Glucose Control in Adult Critically Ill Patients
Active, not recruiting·KKU Leuven·Phase 3·NCT03665207·9,230 enrolled
TESTO-TRIAL: Use of Testosterone in Critically Ill Patients
Active, not recruiting·LLeticia Maria Defendi Barboza Marson·Phase 4·NCT06592144·94 enrolled
Page 1 of 8

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)